TipRanks
Aprogen Biologics (KR:003060)
:003060
South Korea Market
003060
Aprogen Biologics
RESEARCH TOOLSreports

Aprogen Biologics (003060) Ratios

― Followers

Aprogen Biologics Ratios

KR:003060's free cash flow for Q2 2026 was ₩-0.42. For the 2026 fiscal year, KR:003060's free cash flow was decreased by ₩ and operating cash flow was ₩-0.58. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.57 0.67 0.78 0.54 1.49
Quick Ratio
 0.35 0.45 0.43 0.23 1.17
Cash Ratio
 0.11 0.11 0.08 0.06 0.15
Solvency Ratio
 -0.21 -0.49 -0.40 -0.44 0.04
Operating Cash Flow Ratio
 -0.16 -0.17 -0.21 -0.21 0.16
Short-Term Operating Cash Flow Coverage
 -0.20 -0.23 -0.30 -0.26 0.19
Net Current Asset Value
₩ -159.28B₩ -151.42B₩ -97.09B₩ -135.85B₩ 66.88B
Leverage Ratios
Debt-to-Assets Ratio
 0.38 0.38 0.26 0.31 0.20
Debt-to-Equity Ratio
 1.09 1.08 0.41 0.49 0.32
Debt-to-Capital Ratio
 0.52 0.52 0.29 0.33 0.24
Long-Term Debt-to-Capital Ratio
 0.16 0.16 0.08 0.08 0.00
Financial Leverage Ratio
 2.82 2.83 1.56 1.60 1.60
Debt Service Coverage Ratio
 -0.15 -0.58 -0.20 -0.68 0.11
Interest Coverage Ratio
 -8.02 -11.49 -9.58 -19.07 46.68
Debt to Market Cap
 9.53 2.02 0.74 0.46 0.22
Interest Debt Per Share
 16.13K 17.83K 12.11K 17.58K 12.85K
Net Debt to EBITDA
 -6.80 -1.94 -2.76 -1.94 6.94
Profitability Margins
Gross Profit Margin
-27.08%-38.81%-11.25%-13.79%41.86%
EBIT Margin
-141.00%-167.82%-104.51%-125.58%23.25%
EBITDA Margin
-32.15%-141.62%-76.18%-101.09%24.55%
Operating Profit Margin
-137.70%-167.82%-78.40%-80.07%19.65%
Pretax Profit Margin
-85.46%-231.31%-155.81%-129.78%10.50%
Net Profit Margin
-90.85%-232.61%-155.81%-135.38%8.57%
Continuous Operations Profit Margin
-84.23%-229.83%-155.81%-132.01%18.82%
Net Income Per EBT
106.31%100.56%100.00%104.31%81.59%
EBT Per EBIT
62.06%137.83%198.74%162.09%53.43%
Return on Assets (ROA)
-14.28%-29.02%-17.76%-20.07%0.83%
Return on Equity (ROE)
-36.87%-81.99%-27.74%-32.08%1.32%
Return on Capital Employed (ROCE)
-34.75%-34.34%-11.91%-16.21%2.49%
Return on Invested Capital (ROIC)
-23.31%-23.13%-6.96%-12.44%1.61%
Return on Tangible Assets
-14.37%-29.28%-17.92%-20.28%0.83%
Earnings Yield
-357.89%-165.41%-57.37%-33.50%0.93%
Efficiency Ratios
Receivables Turnover
 1.77 1.45 2.93 5.90 3.67
Payables Turnover
 23.07 33.08 37.56 74.57 9.95
Inventory Turnover
 2.44 1.97 1.43 2.07 0.72
Fixed Asset Turnover
 0.27 0.23 0.21 0.27 0.20
Asset Turnover
 0.16 0.12 0.11 0.15 0.10
Working Capital Turnover Ratio
 -1.05 -1.37 -1.28 27.21 0.31
Cash Conversion Cycle
 340.48 426.85 369.33 233.68 566.56
Days of Sales Outstanding
 206.63 252.58 124.44 61.86 99.49
Days of Inventory Outstanding
 149.67 185.30 254.60 176.71 503.75
Days of Payables Outstanding
 15.82 11.03 9.72 4.89 36.68
Operating Cycle
 356.30 437.89 379.04 238.58 603.24
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.31K -2.89K -2.35K -3.20K 2.45K
Free Cash Flow Per Share
 -2.58K -3.62K -3.53K -5.91K 2.30K
CapEx Per Share
 273.69 727.27 1.17K 2.70K 147.11
Free Cash Flow to Operating Cash Flow
 1.12 1.25 1.50 1.84 0.94
Dividend Paid and CapEx Coverage Ratio
 -8.44 -3.97 -2.01 -1.19 16.65
Capital Expenditure Coverage Ratio
 -8.44 -3.97 -2.01 -1.19 16.65
Operating Cash Flow Coverage Ratio
 -0.15 -0.17 -0.20 -0.19 0.19
Operating Cash Flow to Sales Ratio
 -0.38 -0.52 -0.46 -0.39 0.39
Free Cash Flow Yield
-175.39%-46.47%-25.38%-17.57%4.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.27 -0.60 -1.74 -2.99 107.81
Price-to-Sales (P/S) Ratio
 0.24 1.41 2.72 4.04 9.23
Price-to-Book (P/B) Ratio
 0.11 0.50 0.48 0.96 1.43
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.57 -2.15 -3.94 -5.69 24.89
Price-to-Operating Cash Flow Ratio
 -0.68 -2.69 -5.90 -10.49 23.40
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 -0.19 0.06 <0.01 -2.94
Price-to-Fair Value
 0.11 0.50 0.48 0.96 1.43
Enterprise Value Multiple
 -7.54 -2.93 -6.33 -5.93 44.55
Enterprise Value
 209.02B 303.91B 324.70B 524.00B 713.12B
EV to EBITDA
 -7.54 -2.93 -6.33 -5.93 44.55
EV to Sales
 2.43 4.15 4.82 6.00 10.94
EV to Free Cash Flow
 -5.78 -6.35 -6.99 -8.45 29.49
EV to Operating Cash Flow
 -6.47 -7.95 -10.48 -15.57 27.72
Tangible Book Value Per Share
 19.14K 20.84K 28.37K 34.51K 47.21K
Shareholders’ Equity Per Share
 13.89K 15.70K 28.74K 35.10K 40.15K
Tax and Other Ratios
Effective Tax Rate
 0.01 <0.01 0.28 -0.02 0.18
Revenue Per Share
 6.16K 5.53K 5.12K 8.32K 6.21K
Net Income Per Share
 -5.60K -12.87K -7.97K -11.26K 531.59
Tax Burden
 1.06 1.01 1.00 1.04 0.82
Interest Burden
 0.61 1.38 1.49 1.03 0.45
Research & Development to Revenue
 0.04 0.04 0.27 0.17 0.03
SG&A to Revenue
 0.20 0.23 0.25 0.21 0.27
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.41 0.22 0.30 0.28 4.61
Currency in KRW